Nanoliposomal irinotecan for use in treating small cell lung cancer

B Adiwijaya, JB Fitzgerald, H Lee - US Patent 11,318,131, 2022 - Google Patents
A61K31/573—Compounds containing cyclopenta [a] hydrophenanthrene ring systems;
Derivatives thereof, eg steroids substituted in position 17 beta by a chain of two carbon …

Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluorouracil (and leucovorin)

JB Fitzgerald, A Kalra, S Leonard, S Braun… - US Patent …, 2021 - Google Patents
5,316,771 A 5,538,954 A 5,543,152 A 5,593,622 A 5,676,971 A 5,783,568 A 5,785,987 A
5,846,458 A 6,110,491 A 6,210,707 B1 6,214,388 B1 6,241,999 B1 6,355,268 B1 6,403,569 …

Methods for treating pancreatic cancer using combination therapies

E Bayever, N Dhindsa, JB Fitzgerald, P Laivins… - US Patent …, 2022 - Google Patents
Provided are methods for treating pancreatic cancer in a patient by administering liposomal
irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one …

Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin

E Bayever, SF Blanchette, JB Fitzgerald… - US Patent …, 2022 - Google Patents
Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil
are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed …

Combination therapy for cancer treatment

SF Blanchette, DC Drummond, JB Fitzgerald… - US Patent …, 2023 - Google Patents
2022-03-24 Assigned to MERRIMACK PHARMACEUTICALS, INC. reassignment
MERRIMACK PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE …